Workshop on support for orphan medicines development by EMA

Today, Montse de Castellarnau, Scientific & Regulatory Affairs Officer at Asphalion, will be attending the “Workshop on support for orphan medicines development”. The workshop is organized by the EMA and it is aimed to facilitate the development of orphan medicines in neglected disease areas. The virtual event will highlight tools and incentives, such as Orphan designation, Protocol Assistance and the PRIME scheme.

Montse de Castellarnau is Medical writer at Asphalion and will participate in this workshop, where she will have the opportunity to interact with the EMA, as well as with stakeholders involved in orphan drugs development.

Asphalion has more than 20 years of experience on Regulatory procedures, and we can support Stakeholders throughout the drug development, including medicines for orphan diseases. If you would like to know more on how Asphalion can assist you, do not hesitate to contact us at info@asphalion.com.